- Home
- Publications
- Publication Search
- Publication Details
Title
Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-12-23
DOI
10.3389/fmed.2020.614393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Digestive Symptoms in COVID-19 Patients With Mild Disease Severity
- (2020) Chaoqun Han et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
- (2020) Furong Qi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients
- (2020) Yun Ling et al. CHINESE MEDICAL JOURNAL
- Medication for COVID-19—an overview of approaches currently under study
- (2020) Ralf Stahlmann et al. Deutsches Arzteblatt International
- Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
- (2020) Daniel E. Freedberg et al. GASTROENTEROLOGY
- Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019.
- (2020) Mulong Du et al. GASTROENTEROLOGY
- Can melatonin reduce the severity of COVID-19 pandemic?
- (2020) Alex Shneider et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- New York clinical trial quietly tests heartburn remedy against coronavirus
- (2020) Brendan Borrell SCIENCE
- Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors
- (2020) Mario Gennaro Mazza et al. BRAIN BEHAVIOR AND IMMUNITY
- Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series
- (2020) Tobias Janowitz et al. GUT
- Binding insight of clinically oriented drug famotidine with the identified potential target of SARS-CoV-2
- (2020) Parth Sarthi Sen Gupta et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Epidemiological features and viral shedding in children with SARS‐CoV‐2 infection
- (2020) Chun‐Zhen Hua et al. JOURNAL OF MEDICAL VIROLOGY
- Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract
- (2020) Jaewon J. Lee et al. Genes
- Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020
- (2020) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis
- (2020) Joseph T. Ortega et al. Biomolecules
- Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission
- (2020) Amarylle S. van Doorn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19
- (2020) Jeffrey F. Mather et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Neurobiology of coronaviruses: Potential relevance for COVID-19
- (2020) Mauro Cataldi et al. NEUROBIOLOGY OF DISEASE
- Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
- (2020) Reed B. Hogan II et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Neuroinflammation and psychiatric illness
- (2013) Souhel Najjar et al. Journal of Neuroinflammation
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More